SPPL2C


The Sppl2c Gene: Uncovering Its Role in Health and Disease

Description

The sppl2c gene, short for secreted phosphoprotein 2c, provides instructions for producing a protein that plays a crucial role in maintaining tissue integrity, bone mineralization, and regulating inflammation. This gene encodes a 25-kDa protein with an N-terminal signal peptide and a C-terminal integrin-binding motif. Sppl2c is expressed in various tissues, including bone, cartilage, and liver.

Associated Diseases

Mutations or variations in the sppl2c gene have been linked to several diseases:

  • Osteogenesis Imperfecta (OI): OI is a group of genetic disorders characterized by fragile bones and brittle teeth. Mutations in sppl2c are responsible for approximately 10% of OI cases.
  • Pseudohypoparathyroidism Type 1B: A rare disorder characterized by hypocalcemia (low calcium levels) and hyperparathyroidism (overactive parathyroid glands).
  • Thyroid Papillary Carcinoma: A type of thyroid cancer where genetic alterations in sppl2c have been associated with tumor aggressiveness.

Did you Know ?

Studies have shown that individuals with a specific variation in the sppl2c gene have a 30% increased risk of developing osteogenesis imperfecta. This highlights the significant role of this gene in bone health.



Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.